Quick Answer
Nuo Therapeutics, Inc. reported Stockholders Equity of -$956.6 thousand for the year ending 2025.
- Nuo Therapeutics, Inc. showed a decrease of -286.2% in Stockholders Equity from 2024 to 2025.
- This data is from Nuo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (24 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $39.80 million | Q2 2013: $35.14 million | Q3 2013: $30.42 million | Q1 2014: $25.03 million | Q2 2014: $15.62 million | Q3 2014: $12.27 million | Q1 2015: $19.91 million | Q2 2015: $19.23 million | Q3 2015: $5.53 million | Q1 2016: -$41.39 million | Q2 2016: $16.81 million | Q3 2016: $14.90 million | Q1 2017: $10.81 million | Q2 2017: $6.91 million | Q3 2017: $8.47 million | Q4 2017: $482.9 thousand | Q1 2018: -$184.4 thousand | Q2 2018: -$273.2 thousand | Q3 2018: -$581.8 thousand | Q1 2019: -$711.9 thousand | Q2 2019: -$1.19 million | Q3 2019: -$1.28 million | Q4 2019: -$1.21 million | Q1 2020: -$996.2 thousand | Q2 2020: -$1.02 million | Q3 2020: -$1.03 million | Q1 2021: -$509.2 thousand | Q2 2021: -$515.8 thousand | Q3 2021: -$522.5 thousand | Q1 2022: $527.2 thousand | Q2 2022: $3.56 million | Q3 2022: $3.15 million | Q1 2023: $1.34 million | Q2 2023: $470.8 thousand | Q3 2023: $726.7 thousand | Q1 2024: $333.4 thousand | Q2 2024: $598.5 thousand | Q3 2024: $890.4 thousand | Q1 2025: -$213.1 thousand | Q2 2025: -$824.6 thousand | Q3 2025: -$419.6 thousand.
- Over the full 24 years of available data (2009 to 2025), Nuo Therapeutics, Inc.'s Stockholders Equity has declined by 198.0%.
- Historical annual values: Fiscal year 2025: -$956.6 thousand | Fiscal year 2024: $513.7 thousand | Fiscal year 2023: $1.04 million | Fiscal year 2022: $2.19 million | Fiscal year 2021: $792.8 thousand | Fiscal year 2021: -$522.5 thousand | Fiscal year 2021: -$515.8 thousand | Fiscal year 2021: -$509.2 thousand | Fiscal year 2020: -$503.5 thousand | Fiscal year 2020: -$1.03 million | Fiscal year 2020: -$1.02 million | Fiscal year 2020: -$996.2 thousand | Fiscal year 2019: -$1.21 million | Fiscal year 2018: -$82.0 thousand | Fiscal year 2017: $482.9 thousand | Fiscal year 2016: $12.49 million | Fiscal year 2016: $17.89 million | Fiscal year 2015: -$36.56 million | Fiscal year 2014: $15.47 million | Fiscal year 2013: $26.31 million | Fiscal year 2012: $38.00 million | Fiscal year 2011: $3.28 million | Fiscal year 2010: -$79.3 thousand | Fiscal year 2009: $976.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: